Align Formate-dependent phosphoribosylglycinamide formyltransferase; 5'-phosphoribosylglycinamide transformylase 2; Formate-dependent GAR transformylase; GAR transformylase 2; GART 2; Non-folate glycinamide ribonucleotide transformylase; Phosphoribosylglycinamide formyltransferase 2; EC 2.1.2.- (characterized)
to candidate WP_079648198.1 B5X82_RS10990 formate-dependent phosphoribosylglycinamide formyltransferase
Query= SwissProt::P33221 (392 letters) >NCBI__GCF_900167915.1:WP_079648198.1 Length = 395 Score = 388 bits (997), Expect = e-112 Identities = 209/383 (54%), Positives = 264/383 (68%), Gaps = 6/383 (1%) Query: 8 LRPAATRVMLLGSGELGKEVAIECQRLGVEVIAVDRYADAPAMHVAHRSHVINMLDGDAL 67 +RP A R++LLGSGELG+E I +RLG VIA D Y APAM VA V++MLD +AL Sbjct: 1 MRPVA-RILLLGSGELGREFTIAAKRLGAYVIACDSYEKAPAMQVADDYEVLSMLDDEAL 59 Query: 68 RRVVELEKPHYIVPEIEAIATDMLIQLEEEGLNVVPCARATKLTMNREGIRRLAAEELQL 127 V+E +P +IVPE+EAI T++L+ E++G +VVP ARAT LTMNR+ IR +AA EL L Sbjct: 60 AAVIEKHRPDHIVPEVEAIRTEVLLDFEDKGYSVVPSARATMLTMNRDRIRDVAANELGL 119 Query: 128 PTSTYRFADSESLFREAVADIGYPCIVKPVMSSSGKGQTFIRSAEQLAQAWKYAQQGGRA 187 TS + +A++ R AV +G PC+VKPVMSSSGKGQ+ + + E + AW YA +G R Sbjct: 120 VTSRFLYAETLEEMRAAVKTVGIPCVVKPVMSSSGKGQSIVTAEEAVDAAWDYAVEGMRG 179 Query: 188 GAGRVIVEGVVKFDFEITLLTVSAVDGVHFCAPVGHRQEDGDYRESWQPQQMSPLALERA 247 RVIVE + FD+EITLLT+ GV FC P+GHRQE GDYRESWQP MS AL A Sbjct: 180 DRQRVIVEAFIAFDYEITLLTIRTRQGVLFCEPIGHRQELGDYRESWQPTPMSKTALAAA 239 Query: 248 QEIARKVVLALGGYGLFGVELFVCGDEVIFSEVSPRPHDTGMVTLISQDLSEFALHVRAF 307 Q++ARKVV LGGYGLFGVE FV G++VIFSE+SPRPHDTGMVTLISQ+L+EF LH RA Sbjct: 240 QDMARKVVDDLGGYGLFGVEFFVAGEQVIFSELSPRPHDTGMVTLISQNLTEFDLHARAI 299 Query: 308 LGLPVGGIRQYGPAASAVILPQLTSQNVTFDNVQNAV----GADLQIRLFGKPEIDGSRR 363 LGLP+ I G +ASAV+L +++ + + A+ G + +RLF KP +RR Sbjct: 300 LGLPIPHIHLNGASASAVLLADRHAEDFRIEGLAEALAPAPGVETDVRLFSKPVTRPNRR 359 Query: 364 LGVALATA-ESVVDAIERAKHAA 385 +GVALA A E D A AA Sbjct: 360 MGVALALAREGTADDARAAARAA 382 Lambda K H 0.320 0.136 0.390 Gapped Lambda K H 0.267 0.0410 0.140 Matrix: BLOSUM62 Gap Penalties: Existence: 11, Extension: 1 Number of Sequences: 1 Number of Hits to DB: 406 Number of extensions: 11 Number of successful extensions: 2 Number of sequences better than 1.0e-02: 1 Number of HSP's gapped: 2 Number of HSP's successfully gapped: 1 Length of query: 392 Length of database: 395 Length adjustment: 31 Effective length of query: 361 Effective length of database: 364 Effective search space: 131404 Effective search space used: 131404 Neighboring words threshold: 11 Window for multiple hits: 40 X1: 16 ( 7.4 bits) X2: 38 (14.6 bits) X3: 64 (24.7 bits) S1: 41 (21.8 bits) S2: 50 (23.9 bits)
This GapMind analysis is from Sep 24 2021. The underlying query database was built on Sep 17 2021.
Each pathway is defined by a set of rules based on individual steps or genes. Candidates for each step are identified by using ublast (a fast alternative to protein BLAST) against a database of manually-curated proteins (most of which are experimentally characterized) or by using HMMer with enzyme models (usually from TIGRFam). Ublast hits may be split across two different proteins.
A candidate for a step is "high confidence" if either:
Otherwise, a candidate is "medium confidence" if either:
Other blast hits with at least 50% coverage are "low confidence."
Steps with no high- or medium-confidence candidates may be considered "gaps." For the typical bacterium that can make all 20 amino acids, there are 1-2 gaps in amino acid biosynthesis pathways. For diverse bacteria and archaea that can utilize a carbon source, there is a complete high-confidence catabolic pathway (including a transporter) just 38% of the time, and there is a complete medium-confidence pathway 63% of the time. Gaps may be due to:
GapMind relies on the predicted proteins in the genome and does not search the six-frame translation. In most cases, you can search the six-frame translation by clicking on links to Curated BLAST for each step definition (in the per-step page).
For more information, see:
If you notice any errors or omissions in the step descriptions, or any questionable results, please let us know
by Morgan Price, Arkin group, Lawrence Berkeley National Laboratory